Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...
Discover last week's top S&P 500 healthcare gainers, major market stories, and groundbreaking pharma deals, including weight-loss drug updates.
A combination, triplet therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results